FDA Warning Letter — Tissue Transplant Technology, Ltd.
The FDA took a Warning Letter action against Tissue Transplant Technology, Ltd. on Oct 30, 2018 (San Antonio, TX). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Tissue Transplant Technology, Ltd.
- Date
- Oct 30, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Center
- CBER
- Location
- San Antonio, TX (United States)